AFS GROUP HEALTH

SAVING MORE LIVES

With over 30 years of experience in the field of biological drugs, the AFS Group has served as the supplier of human-derived plasma products to our country and was the architect of the project to establish the first and only human-derived plasma products production factory in our country and was the founding partner of the consortium that won the tender. We continue to work to bring Gen 3 and Gen 4 FDA-approved rDNA Factor VIII and Factor IX recombinant products used in the treatment of hemophilia and Von Willebrand syndrome, recombinant production technologies, and immuno-oncology drugs to our country in the future.

With its collaborations in the field of Biotechnology, the AFS Group; Supply of RNA-based breath lung cancer early diagnosis kits and Enviroklenz air purification systems with Fast-Act filters, which purify the environment from the undesirable effects of radon gas, which threatens us in our current home and/or workplace life by leaking from the house foundations in geothermal areas, which causes gene lung cancer. provides.

In the field of Group Environmental Health and Health Services; It supplies high-tech systems for the destruction of medical and medical waste, which is produced in tons every day in hospitals, blood centers, dialysis centers and causes air pollution when disposed of by burning, without leaving the health centers and turning them into harmless domestic waste, and provides 50% to 65% resources to the institutions. It offers savings opportunities.